Raw Emotion Grows in UK Debate Over Gene-Edited Crops
Will fears of climate change cause Great Britain to loosen its restrictions on genetically edited crops?
Telehealth Grew Dramatically During the Pandemic. Now Let’s Look at the Fraud.
COVID-19 caused a huge spike in demand for telehealth services, but it opened the door for bad actors as well.
The Revolution Will Not Be Tenderized
We’re more than a decade into the alt-protein revolution. Will meatless beef ever replace the real thing?
Is Your DNA Data Safe in Blackstone’s Hands?
The Wall Street giant’s big bet on Ancestry.com drives home the financial realities facing the consumer genomic revolution.
Inside the Movement to Decolonize Psychedelic Pharma
As Western medicine brings psychedelics into mainstream use, a growing movement is innovating new business models grounded in reciprocity and inclusion.
Get Up to Speed On the State of Eco-Fashion
The race is on to bioengineer carbon-neutral, recyclable, biodegradable, and affordable materials.
The Dawn of Cheap and Easy DNA Writing
These startups are developing new ways to reprogram biology by producing custom genes from scratch.
The Wristband that Gives You Superpowers
Neuroscientist David Eagleman aims to give deaf people a new way to hear—and upgrade everyone else’s senses too. by Steven Kotler
Trouble in the High-Rise Hothouse
Big indoor farms are attracting big investments. But transforming agriculture might depend on putting nanofarms everywhere — maybe even in your home. by Corby Kummer
The “Clean Meat” Industry Has a Dirty Little Secret
Manufactured meat may be safer and better — but first, producers need to get rid of the icky ingredients.
Reset Your DNA to Slow the Clock
A new epigenetic test that tracks molecular aging claims to show you how to stay biologically young.
The Latest Biotech Growth Market Might be Crap
There’s gold in your gut—and startups are mining it with microbiome science. The biggest hurdle? Stool doesn’t scale.
This Scientist-Turned-VC Wants to Extend Life
Since he was a child, James Peyer has been obsessed with stopping aging. Now he has a fund — and a plan.
Who Will Be the Google of Genomics?
The first company to offer whole genome sequencing for free can build the most valuable advertising engine in the world. by Andrew Hessel